Canadian pensions join stampede out of Chinese stocks amid prolonged rout, delisting threat

Skip to content The Canada Pension Plan Investment Board sold all its U.S.-listed shares in Chinese tech giant Alibaba this summer, part of a multibillion-dollar sell-off of public assets headquartered in the country. It’s one of several major Canadian pension funds, including the British Columbia Investment Management Corporation (BCI) and the Caisse de Dépôt et… Continue reading Canadian pensions join stampede out of Chinese stocks amid prolonged rout, delisting threat

Jamie Dimon’s S&P 500 bear market: Brutal, but far from unimaginable

Don’t be surprised if the S&P 500 loses another one-fifth of its value Author of the article: Bloomberg News Lu Wang and Peyton Forte JPMorgan Chase and Co. chief executive Jamie Dimon. Photo by Evelyn Hockstein/Reuters files Jamie Dimon says don’t be surprised if the S&P 500 loses another one-fifth of its value. While such… Continue reading Jamie Dimon’s S&P 500 bear market: Brutal, but far from unimaginable

Cash may be king, but cash flow rules in times of volatility

Cash-flow-producing assets can be one of the most powerful tools available for boosting investor returns in the long run Traders work during the opening bell at the New York Stock Exchange on Wall Street in New York City. Photo by ANGELA WEISS/AFP via Getty Images files As the capital markets continue their downward slide, many… Continue reading Cash may be king, but cash flow rules in times of volatility

Stock Market Today: Stocks Finish Lower After Inflation Data, Fed Minutes

Wednesday’s choppy trading ended with a loss for stocks. Modest declines for the Nasdaq Composite (-0.1% at 10,417) and the S&P 500 Index (-0.3% at 3,577) had the two indexes extending their losing streaks to six days, while the Dow Jones Industrial Average shed 0.1% to 29,210. In focus today was September’s producer price index… Continue reading Stock Market Today: Stocks Finish Lower After Inflation Data, Fed Minutes

Wholesale Inflation Comes In Hot: What the Experts Are Saying

A reading of inflation at the wholesale level surprised to the upside Wednesday, stoking fears that tomorrow’s report on consumer prices will likewise show that inflation remains out of the Federal Reserve’s control.  The producer price index (PPI) rose 0.4% in September, well ahead of economists’ estimate for a gain of 0.2%. Year-over-year, PPI rose… Continue reading Wholesale Inflation Comes In Hot: What the Experts Are Saying

U.S. Markets Rise After Lengthy Sell-off, Despite Fears of Rate Hikes

The S&P 500 and the Nasdaq bounced on Wednesday after a five-day selloff, but inflation and rate hike worries capped the gains after a higher-than-expected rise in September producer prices. The Labor Department’s producer prices index rose 8.5% in the 12 months through September, slightly higher than an estimated 8.4% rise. The reading was still… Continue reading U.S. Markets Rise After Lengthy Sell-off, Despite Fears of Rate Hikes

US stocks dip as Fed minutes show continued hawkish resolve while CPI report awaits

US stocks dipped Wednesday after Fed minutes reiterated the central bank’s goal of taming inflation.  The S&P 500 notched its sixth consecutive loss. Investors also await September consumer inflation data due out Thursday morning.  Loading Something is loading. Thanks for signing up! Access your favorite topics in a personalized feed while you’re on the go.… Continue reading US stocks dip as Fed minutes show continued hawkish resolve while CPI report awaits

Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine

Moderna spiked as much as 17% on Wednesday after the company teamed up with Merck to develop personalized cancer vaccines.Merck will pay Moderna $250 million under the agreement, which was initially struck in 2016.  Data from an ongoing phase 2 trial of Moderna’s vaccine used in combination with Merck’s Keytruda is expected in the fourth quarter.… Continue reading Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine